LIPOSOMAL AMPHOTERICIN-B IN HEPATIC CANDIDOSIS

被引：2
|
作者：
SHARLAND, M [1 ]
HAY, RJ [1 ]
DAVIES, EG [1 ]
机构：
[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST JOHNS INST DERMATOL,LONDON,ENGLAND
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 1994年 / 70卷 / 06期
关键词：
D O I：
10.1136/adc.70.6.546
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
A 4 year old girl treated with a standard chemotherapy protocol for acute lymphoblastic leukaemia developed hepatic candidosis during the consolidation phase. This relapsed after a prolonged course of amphotericin B and flucytosine. An eight week course of liposomal amphotericin produced a marked clinical improvement which was sustained for one year. A subsequent relapse was associated with transformation to myelodysplastic leukaemia.
引用
收藏
页码：546 / 547
页数：2
相关论文
共 50 条
  • [1] TREATMENT OF HEPATIC CANDIDOSIS WITH LIPOSOMAL AMPHOTERICIN-B IN PATIENT WITH ACUTE-LEUKEMIA
    HUDSON, J
    SCOTT, GL
    WARNOCK, DW
    [J]. LANCET, 1991, 338 (8781): : 1534 - 1535
  • [2] LIPOSOMAL AMPHOTERICIN-B
    VINCENT, M
    WEBSTER, MH
    PETHER, JVS
    [J]. LANCET, 1992, 339 (8789): : 374 - 375
  • [3] TREATMENT OF MURINE CANDIDOSIS AND CRYPTOCOCCOSIS WITH A UNILAMELLAR LIPOSOMAL AMPHOTERICIN-B FORMULATION (AMBISOME)
    ADLERMOORE, JP
    CHIANG, SM
    SATORIUS, A
    GUERRA, D
    MCANDREWS, B
    MCMANUS, EJ
    PROFFITT, RT
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 : 63 - 71
  • [4] LIPOSOMAL AMPHOTERICIN-B (AMBISOME) FOR TREATMENT OF CUTANEOUS WIDESPREAD CANDIDOSIS IN AN INFANT WITH METHYLMALONIC ACIDEMIA
    STOCKLER, S
    LACKNER, H
    GINTER, G
    SCHWINGER, W
    PLECKO, B
    MULLER, W
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 (12) : 981 - 983
  • [5] SUCCESSFUL TREATMENT OF FOCAL HEPATIC CANDIDIASIS WITH LIPOSOMAL AMPHOTERICIN-B
    OCONNELL, B
    CROTTY, G
    CAFFERKEY, MT
    STEPHENS, R
    MCDONALD, GSA
    MCCANN, SR
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 1992, 161 (12) : 664 - 665
  • [6] Amphotericin-B/amphotericin-B liposomal/voriconazoleVarious toxicities: case report
    [J]. Reactions Weekly, 2016, 1583 (1) : 85 - 85
  • [7] Amphotericin-B/amphotericin-B liposomal/immunosuppressantsVarious toxicities: case report
    [J]. Reactions Weekly, 2019, 1749 (1) : 42 - 42
  • [8] AMPHOTERICIN-B EFFECTIVENESS IN THE TREATMENT OF SYSTEMIC CANDIDOSIS
    LOPEZMARTINEZ, R
    PIZZUTOCHAVEZ, J
    [J]. ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1986, 262 (01): : 134 - 134
  • [9] COMPARISON OF LIPOSOMAL AMPHOTERICIN-B TO AMPHOTERICIN-B FOR TREATMENT OF MURINE CRYPTOCOCCAL MENINGITIS
    ALBERT, MM
    STAHLCARROLL, TL
    LUTHER, MF
    GRAYBILL, JR
    [J]. JOURNAL DE MYCOLOGIE MEDICALE, 1995, 5 (01): : 1 - 6
  • [10] LIPOSOMAL AMPHOTERICIN-B AND ERYTHROCYTE ECHINOCYTOSIS
    SMITH, OP
    PRENTICE, HG
    [J]. BONE MARROW TRANSPLANTATION, 1991, 8 (02) : 155 - 156
12345